A calf thymus acid lysate improves clinical symptoms and T-cell defects in the early stages of HIV infection: Second report
- 1 December 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (12) , 1915-1919
- https://doi.org/10.1016/0277-5379(87)90059-9
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- HIV infection: facts and hypothesesImmunology Today, 1986
- AIDS and the thymusImmunology Today, 1986
- Circulating thymulin and thymosin-α1 activity in pediatric acquired immune deficiency syndrome: In vivo and in vitro studiesThe Journal of Pediatrics, 1986
- Clinical improvement and partial correction of the T cell defects of acquired immunodeficiency syndrome (AIDS) and lymphoadenopathy syndrome (LAS) by a calf thymus acid lysateEuropean Journal of Cancer and Clinical Oncology, 1986
- RIBAVIRIN IN HTLV-III:LAV INFECTION OF INFANTSThe Lancet, 1986
- ARE CONDITIONS LINKED WITH T-CELL STIMULATION NECESSARY FOR PROGRESSIVE HTLV-III INFECTION?The Lancet, 1986
- The Walter Reed Staging Classification for HTLV-III/LAV InfectionNew England Journal of Medicine, 1986
- URINARY NEOPTERIN AND BIOPTERIN LEVELS IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEXThe Lancet, 1985
- Low Serum Thymic Hormone Levels in Patients with Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983
- Elevated Urinary Neopterin Levels in Patients with the Acquired Immunodeficiency Syndrome (AIDS). A Preliminary ReportHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1983